India's Pharmaceutical Exports

Country Profile

Syria

Syria is an emerging destination for Indian pharmaceutical exports — $12.2M in FY 2025–26. Vaccines accounts for 39% of shipments, with vaccines contributing $4.72M.

🇸🇾 $12.2M · 0.6× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$12.2M
Exports FY2025–26 DGCIS
0.6×
Growth FY2015→2026
39%
Vaccines Share
5
Product Categories Supplied
12
Years of Trade Data
Syria is an emerging destination for Indian pharmaceutical exports — $12.2M in FY 2025–26. Vaccines accounts for 39% of shipments, with vaccines contributing $4.72M.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Vaccines $4.72M (38.8%) Medicines $3.62M (29.7%) Medicine Ingredients $2.99M (24.6%) Traditional & Herbal $498K (4.1%) Surgical & Hospital Supplies $344K (2.8%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Syria in the RBI overseas direct investment dataset (2011–2026).